MILLIONS OF PAXLOVID PILLS FROM PFIZER EXPIRE - COST $2.2 BILLION TO $4.5 BILLION

In April 2022, Pfizer obtained approval from EMA for the commercialization of a " Covid pill " known by the name PAXLOVID.

Want to read more?

Subscribe to wwhisper.com to keep reading this exclusive post.

Subscribe Now